Search Results 331-340 of 16259 for GLP-1 agonist

  1. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors. Print ...

  2. Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms - Mayo Clinic

    Use of glucagon-like peptide 1 (GLP1) receptor agonists or Sodium-Glucose Transport Protein 2 (SGLT2); Gastric inhibitory polypeptide (GIP)- glucagon-like ...

  3. Loperamide (oral route) - Side effects & dosage - Mayo Clinic

    Adults and children 13 years of age and older—At first, 4 milligrams (mg) (2 capsules) after the first loose bowel movement, then 2 mg (1 capsule) after each ...

  4. A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti-TIM-3 (T cell immunoglobulin and mucin containing protein-3) antibody TSR- ...

  5. A Study of Adjustable Gastric Banding and Its Effects on After Meal Glucose Metabolism, Independent of Weight Loss - Mayo Clinic

    Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and ...

  6. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients with ...

  7. Calcium channel blockers - Mayo Clinic

    Long-acting medicines are slowly released. So they last longer. Which one is best for you depends on your health and the condition being treated. Examples of ...

  8. Clopidogrel (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Armodafinil; Asciminib ...

  9. Glatiramer (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This may occur 1 hour after injection, months to years after receiving this medicine. Check with your doctor right away if you have chest tightness, cough ...

  10. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.